Boston Biomedical

Boston Biomedical, Inc. is a privately held company headquartered in Cambridge, Massachusetts. The company employs 19 people and generates approximately $50 million in annual revenue. Boston Biomedical is a leading developer of novel cancer therapeutics focused on improving patient outcomes. The company provides a comprehensive range of services from drug discovery and medicinal chemistry to preclinical development, pharmacology, pharmaceutical development, and clinical trials. Their expertise extends to global clinical trials, regulatory affairs, and commercialization, making them a fully integrated oncology drug research and development company. The company distinguishes itself through its innovation-driven culture, scientific leadership, and drug development expertise. Boston Biomedical's commitment to advancing the development of novel therapeutics for cancer patients is evident in its numerous accomplishments, including the advancement of multiple compounds and clinical programs. For more information, please visit www.bostonbiomedical.com/.